CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive trial opens lifeline with unapproved cord blood for desperate patients
Disease control Recruiting nowThis study provides access to cord blood units that are not yet FDA-approved for patients who need a transplant for blood cancers or other serious blood/immune disorders. It aims to see how well patients' immune systems recover after receiving these transplants and to monitor for…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for tough blood cancers: optimized transplant trial seeks to control disease
Disease control Recruiting nowThis study is collecting information on patient outcomes after receiving a cord blood transplant using Memorial Sloan Kettering's optimized procedure. It aims to see how well this standard transplant approach works for adults with high-risk blood cancers like leukemia, lymphoma, …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC